Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.

Frater J. et al, (2021), Lancet HIV, 8, e474 - e485

Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern

Skelly DT. et al, (2021)

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype.

Thornhill JP. et al, (2019), Mucosal Immunol, 12, 1212 - 1219

Development of a Simple In Vitro Assay to Assess Digestion of the Extracellular Matrix of the Human Pancreas by Collagenase Enzyme Blends.

Spiers RM. et al, (2018), Cell Transplant, 27, 1039 - 1046

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.

Martin GE. et al, (2018), Front Immunol, 9

Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.

Hoffmann M. et al, (2016), PLoS Pathog, 12

Structured observations reveal slow HIV-1 CTL escape.

Roberts HE. et al, (2015), PLoS Genet, 11

HIV-1 DNA predicts disease progression and post-treatment virological control.

Williams JP. et al, (2014), Elife, 3

HIV-1-specific CD4(+) responses in primary HIV-1 infection predict disease progression.

Frater J. et al, (2014), AIDS, 28, 699 - 708

Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.

Yager N. et al, (2013), AIDS, 27, 313 - 323

Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections.

Barnes E. et al, (2010), J Infect Dis, 202, 1482 - 1485

Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa.

Huang K-HG. et al, (2009), Antivir Ther, 14, 975 - 984

Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.

Frater AJ. et al, (2007), J Virol, 81, 6742 - 6751

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.

Milicic A. et al, (2005), J Immunol, 175, 4618 - 4626

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound

Scriba TJ. et al, (2005), Journal of Clinical Investigation, 115, 443 - 450

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.

Scriba TJ. et al, (2005), J Clin Invest, 115, 443 - 450